You are here

  • Home
  • Archive
  • Volume 29, Issue 4
  • Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study

Article info

Article menu
Download PDFPDF
Original research
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study

Authors

  • Noelia Fernández-Bargiela Service of Pharmacy, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Sandra Rotea-Salvo Service of Pharmacy, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Luis Margusino-Framiñán Service of Pharmacy, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Vanesa Balboa-Barreiro Clinical Epidemiology and Biostatistics Unit, Biomedical Research Institute of A Coruña (INIBIC), Universitary Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña (UDC), A Coruña, Spain PubMed articlesGoogle scholar articles
  • Isabel Martín-Herranz Service of Pharmacy, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Ángeles Castro-Iglesias Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain Service of Infectious Internal Medicine, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Álvaro Mena-De-Cea Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain Service of Infectious Internal Medicine, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Soledad López-Calvo Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain Service of Infectious Internal Medicine, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Pilar Vázquez-Rodríguez Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain Service of Infectious Internal Medicine, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Enrique Míguez-Rey Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain Service of Infectious Internal Medicine, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain PubMed articlesGoogle scholar articles
  • Purificación Cid-Silva Service of Pharmacy, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña, Spain Division of Clinical Virology, Biomedical Research Institute of A Coruña (INIBIC), University Hospital of A Coruña (CHUAC), SERGAS, Universitary of A Coruña, A Coruña, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Purificación Cid-Silva, Service of Pharmacy, Universitary Hospital of A Coruña (CHUAC), SERGAS, A Coruña 15006, Spain; purificacion.cid.silva{at}sergas.es
View Full Text

Citation

Fernández-Bargiela N, Rotea-Salvo S, Margusino-Framiñán L, et al
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study
European Journal of Hospital Pharmacy 2022;29:207-211.

Publication history

  • Received May 19, 2020
  • Revised July 19, 2020
  • Accepted August 18, 2020
  • First published October 13, 2020.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.